IBRS19007 / FLEX Registry / Ajay Dhakal
Basic Study Information
Purpose:Location: University of Rochester - Pluta Cancer Center
The FLEX Registry will be implemented to operate as a large-scale, population based,
prospective registry. All patients with stage I to III breast cancer who receive MammaPrint®
and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX
Registry, which is intended to enable additional study arms at low incremental effort
and cost. FLEX Registry will utilize an adaptive design, where additional targeted
substudies and arms can be added after the initial study is opened.
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Lauren Mitchell
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search